Clinical trials data
Stroop Color-Word Test in depression and bipolar disorder trials: 138 registered studies
Every registered depression and bipolar disorder study on ClinicalTrials.gov that names the Stroop Color-Word Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered depression and bipolar disorder studies name it in an outcome measure
- 138
- Name it in a primary outcome, 28%
- 38 of 138
Tests named in the same studies
- 1
Trail Making Test57 studies, 13 as a primary outcome
- 2
Verbal Fluency35 studies, 8 as a primary outcome
- 3
Verbal Learning33 studies, 4 as a primary outcome
- 4
Digit Span Test32 studies, 13 as a primary outcome
- 5
Symbol Coding24 studies, 12 as a primary outcome
- 6
Card Sorting Test (Berg)23 studies, 2 as a primary outcome
- 7
Go/No-Go Task14 studies, 7 as a primary outcome
- 8
Emotional Stroop Task13 studies, 6 as a primary outcome
- 9
Category Fluency12 studies, 5 as a primary outcome
- 10
N-Back Task11 studies, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 3 | 1 |
| 2006 | 1 | 0 |
| 2007 | 2 | 0 |
| 2008 | 1 | 0 |
| 2009 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 3 | 0 |
| 2012 | 4 | 1 |
| 2013 | 6 | 1 |
| 2014 | 7 | 0 |
| 2015 | 3 | 1 |
| 2016 | 3 | 0 |
| 2017 | 2 | 0 |
| 2018 | 9 | 1 |
| 2019 | 13 | 4 |
| 2020 | 10 | 4 |
| 2021 | 12 | 5 |
| 2022 | 5 | 1 |
| 2023 | 16 | 8 |
| 2024 | 12 | 6 |
| 2025 | 14 | 3 |
| 2026 | 7 | 1 |
Phases and study sizes
By phase
- Early phase 13 studies, 0 as a primary outcome
- Phase 12 studies, 0 as a primary outcome
- Phase 1/22 studies, 0 as a primary outcome
- Phase 213 studies, 5 as a primary outcome
- Phase 2/32 studies, 0 as a primary outcome
- Phase 35 studies, 0 as a primary outcome
- Phase 410 studies, 3 as a primary outcome
- Not applicable90 studies, 27 as a primary outcome
- Observational11 studies, 3 as a primary outcome
Participants per study
- Phase 272 median, 42 to 168
- Phase 441 median, 22 to 79
- Not applicable68 median, 40 to 111
- Observational80 median, 49 to 112
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 11 | 72 | 42 to 168 |
| Phase 4 | 10 | 41 | 22 to 79 |
| Not applicable | 88 | 68 | 40 to 111 |
| Observational | 11 | 80 | 49 to 112 |
When depression and bipolar disorder trials measure it
Latest time point of each outcome
- Within a day16 outcomes, 5 as a primary outcome
- Up to 4 weeks18 outcomes, 3 as a primary outcome
- 1 to 3 months51 outcomes, 17 as a primary outcome
- 3 to 6 months23 outcomes, 5 as a primary outcome
- 6 to 12 months14 outcomes, 4 as a primary outcome
- 1 to 2 years4 outcomes, 1 as a primary outcome
- Over 2 years4 outcomes, 0 as a primary outcome
- No duration given8 outcomes, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
130 of the 138 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting25 studies, 9 as a primary outcome
- Not yet recruiting7 studies, 0 as a primary outcome
- Active, not recruiting7 studies, 1 as a primary outcome
- Completed63 studies, 22 as a primary outcome
- Stopped early15 studies, 3 as a primary outcome
- Status unknown21 studies, 3 as a primary outcome
What they test
- Behavioral42 studies, 15 as a primary outcome
- Drug35 studies, 9 as a primary outcome
- Device37 studies, 7 as a primary outcome
- Dietary supplement5 studies, 0 as a primary outcome
- Procedure3 studies, 1 as a primary outcome
- Diagnostic test2 studies, 1 as a primary outcome
- Biological3 studies, 1 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Other22 studies, 7 as a primary outcome
- None given7 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States38 studies, 12 as a primary outcome
- China15 studies, 3 as a primary outcome
- Canada14 studies, 6 as a primary outcome
- France12 studies, 1 as a primary outcome
- Germany7 studies, 0 as a primary outcome
- Brazil6 studies, 3 as a primary outcome
- Spain6 studies, 0 as a primary outcome
- Poland4 studies, 1 as a primary outcome
- Denmark3 studies, 0 as a primary outcome
- Finland3 studies, 0 as a primary outcome
- Hong Kong3 studies, 1 as a primary outcome
- Italy3 studies, 2 as a primary outcome
34 countries in all. A study with sites in several counts in each; 7 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed depression and bipolar disorder studies that name the Stroop Color-Word Test: 26 of 63, 41%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed depression and bipolar disorder studies that name the Stroop Color-Word Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 8, 13% | 776, 10% |
| Results on ClinicalTrials.gov only | 7, 11% | 1,139, 14% |
| A results paper only | 11, 17% | 1,711, 22% |
| Neither | 37, 59% | 4,327, 54% |
The 138 studies
138 studies match. 38 name the Stroop Color-Word Test in a primary outcome. Median size 66 participants. Median time to the primary outcome: 8 weeks.
Loading 138 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 3 | 1 |
| 2006 | 1 | 0 |
| 2007 | 2 | 0 |
| 2008 | 1 | 0 |
| 2009 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 3 | 0 |
| 2012 | 4 | 1 |
| 2013 | 6 | 1 |
| 2014 | 7 | 0 |
| 2015 | 3 | 1 |
| 2016 | 3 | 0 |
| 2017 | 2 | 0 |
| 2018 | 9 | 1 |
| 2019 | 13 | 4 |
| 2020 | 10 | 4 |
| 2021 | 12 | 5 |
| 2022 | 5 | 1 |
| 2023 | 16 | 8 |
| 2024 | 12 | 6 |
| 2025 | 14 | 3 |
| 2026 | 7 | 1 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 6, NIH 2, other 130. Interventional 127, observational 11.
As a primary outcomeSecondary or other outcomeThe Stroop Color-Word Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07892326 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants200 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07892287 | Start2027 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants20 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07755839 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Cancer, Anxiety, PTSD and OCD | Participants60 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07735910 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Depression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07665840 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD | Participants67 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07664852 | Start2026 | PhasePhase 3 | ConditionsDepression and bipolar disorder | Participants126 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07652775 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Depression and bipolar disorder | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07508215 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07350226 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants86 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07319143 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07309302 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants64 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07258914 | Start2024 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Autism | Participants25 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07247370 | Start2025 | PhasePhase 1/2 | ConditionsDepression and bipolar disorder, Substance use and addiction | Participants20 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07098533 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Aging, frailty and exercise | Participants70 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07039903 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, ADHD | Participants68 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06922409 | Start2025 | PhaseNot applicable | ConditionsStroke, Depression and bipolar disorder, Sleep and sleep disorders, Pain and fatigue | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06913309 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants168 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06897553 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion, Depression and bipolar disorder, COVID-19 and long COVID, Anxiety, PTSD and OCD | Participants44 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06895863 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants78 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06813313 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants108 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06777693 | Start2024 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants24 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06758206 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants64 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06714643 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants105 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06708026 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants46 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06665633 | Start2021 | PhasePhase 1 | ConditionsBrain injury and concussion, Depression and bipolar disorder | Participants40 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many depression and bipolar disorder trials use the Stroop Color-Word Test?
138 registered depression and bipolar disorder studies on ClinicalTrials.gov name it in an outcome measure, 38 of them in a primary outcome: 11% of the condition's 1,247 studies with a cognitive outcome, against 12% of all of them. It is the 6th most named test in depression and bipolar disorder trials.
Which tests do depression and bipolar disorder trials use with the Stroop Color-Word Test?
The Trail Making Test (57 studies), Verbal Fluency (35 studies) and Verbal Learning (33 studies).
How many participants do phase 2 depression and bipolar disorder trials that use the Stroop Color-Word Test enroll?
Half of the phase 2 studies that name it enroll 72 participants or fewer, and the middle half enroll 42 to 168. 11 of them give a size.
When do depression and bipolar disorder trials measure the Stroop Color-Word Test?
Half of the primary outcomes that name the Stroop Color-Word Test are measured within 8 weeks of the start, and the middle half from 6 weeks to 15 weeks. 35 primary outcomes give a duration.
How many completed depression and bipolar disorder trials that use the Stroop Color-Word Test have reported results?
26 of the 63 completed studies that name it, 41%, have reported results: 15 posted them on ClinicalTrials.gov, 19 have a results paper linked to the registry record, and 8 did both. The other 37 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Stroop Color-Word Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.